TELOMIR PHARMACEUTICALS INC (TELO)
US87975F1049 - Common Stock
TELOMIR PHARMACEUTICALS INC
NASDAQ:TELO (12/17/2024, 9:32:16 PM)
After market: 4.91 0 (0%)4.91
-0.03 (-0.61%)
Company Profile
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The company is headquartered in Tampa, Florida and currently employs 1 full-time employees. The company went IPO on 2024-02-09. The firm operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acid’s (DNA) protective telomere caps to affect age reversal. The company selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
Company Info
TELOMIR PHARMACEUTICALS INC
900 West Platt Street, Suite 200
Tampa FLORIDA
P: 18138642562
Employees: 1
Website: https://telomirpharma.com/
TELO News
5 days ago - ChartmillTop movers in Friday's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
6 days ago - ACCESSWIRETelomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price15 days ago - ACCESSWIRETelomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1a month ago - ACCESSWIRETelomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-13 months ago - InvezzBioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO), Science of Longevity Featured in Upcoming Episode of “Health Uncensored with Dr. Drew”Telomir Pharmaceuticals (NASDAQ: TELO), a preclinical-stage biotechnology company seeking to lead developments in longevity science through the treatment of age-related conditions, will be spotlighted during the upcoming episode of “Health Uncensored with Dr. Drew.” The show will be broadcast on Fox Business Network at 5:30 p.m. EST on Sept. 29, 2024. Dr. Drew will talk […]
3 months ago - ACCESSWIRETelomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This SundayTELO Twits
Here you can normally see the latest stock twits on TELO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
